Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
41.86%
GROSS MARGIN AVG 15Y
11.75%
GROSS MARGIN AVG 20Y
12.69%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 679 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$60.32M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
50.00%
5Y Avg
33.33%
Market Cap
$60.12M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$60.24M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.10M
Gross Margin
0.00%
TTM Avg
23.12%
3Y Avg
20.52%
5Y Avg
13.68%
Market Cap
$63.30M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$63.78M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
50.00%
5Y Avg
66.67%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | $61.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.32M | 100.00% | 100.00% | 50.00% | 33.33% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| PDS Biotechnology Corporation (PDSB)vs › | $60.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Fractyl Health, Inc. (GUTS)vs › | $59.10M | 0.00% | 23.12% | 20.52% | 13.68% |
| InterCure Ltd. (INCR)vs › | $63.14M | 14.40% | 12.47% | 23.60% | 30.84% |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | 0.00% | 0.00% | 0.00% | 0.00% |
| Alps Group Inc (ALPS)vs › | $63.23M | 32.09% | 26.51% | 26.11% | 26.57% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | 50.00% | 66.67% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.13M | 70.07% | 73.26% | 61.08% | 58.36% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 100.00% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | -11266.84% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 174.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 174.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 33.81% |
| 2017-03-31 | 22.26% |
| 2016-12-31 | 24.54% |
| 2016-09-30 | 24.09% |
| 2016-06-30 | 21.55% |
| 2016-03-31 | 24.24% |
| 2015-12-31 | 27.24% |
| 2015-09-30 | 25.90% |
| 2015-06-30 | 18.61% |
| 2015-03-31 | 25.10% |
| 2014-12-31 | 24.25% |
| 2014-09-30 | 21.14% |
| 2014-06-30 | 9.75% |
| 2014-03-31 | 20.00% |
| 2013-12-31 | 23.16% |
| 2013-09-30 | 26.10% |
| 2013-06-30 | 19.93% |
| 2013-03-31 | 20.90% |
| 2012-12-31 | 18.17% |
| 2012-09-30 | 19.24% |
| 2012-06-30 | 18.67% |
| 2012-03-31 | 18.25% |
| 2011-12-31 | 18.65% |
| 2011-09-30 | 18.28% |
| 2011-06-30 | 16.50% |
| 2011-03-31 | 16.48% |
| 2010-12-31 | 15.32% |
| 2010-09-30 | 15.16% |
| 2010-06-30 | 14.85% |
| 2010-03-31 | 15.96% |
| 2009-12-31 | 15.20% |
| 2009-09-30 | 16.73% |
| 2009-06-30 | 15.62% |
| 2009-03-31 | 16.61% |
| 2008-12-31 | 15.83% |
| 2008-09-30 | 20.18% |
| 2008-06-30 | 23.13% |
| 2008-03-31 | 16.33% |
| 2007-12-31 | 16.18% |
| 2007-09-30 | 0.00% |
